Stocks Just Did This For the First Time In 2 Years

A relatively high percentage of S&P 500 Index (SPX) stocks are at new annual highs, marking a signal not seen since 2014

Dec 13, 2016 at 10:53 AM
facebook twitter linkedin


Although the S&P 500 Index (SPX) just snapped its longest winning streak in two years, the broad-market barometer has been on a quest for record highs, hitting all-time intraday peaks in each of the past five sessions (including today). As such, 30% of optionable S&P stocks have notched 52-week highs in the past 10 trading days -- a signal not sounded since 2014. If history is any indicator, stocks could experience some weakness over the next month, but stronger-than-usual upside three months from now.

According to Schaeffer's Senior Quantitative Analyst Rocky White, this level of SPX stocks at new highs has been achieved only eight other times since 2005. The last signal -- counting only the first one in three months -- was in December 2014, which resulted in a one-week pullback of 3.52%, and a one-month loss of 2.38% for the SPX.


SPX chart 1 Dec 13

SPX new highs signal Dec 13


As alluded to earlier, the S&P tends to underperform in the short term after these signals. The average return is negative through one month after a signal, compared to positive anytime returns since 2005. Further, the index has been higher just 37.5% of the time two weeks out, compared to 59.6% anytime, and was up just half the time one month after a signal. 

However, in the longer term, the S&P tends to outperform after these signals. Three months out, the SPX has averaged a return of 3.41% -- more than double its anytime three-month return -- and was higher three out of four times. Six months after a signal, the index has been higher a whopping 87.5% of the time, compared to 72.3% anytime, with a healthier-than-usual return of 4.88%.


SPX signal 2 Dec 13

Meanwhile, only 20.6% of S&P 500 Index components are at least 20% off their 52-week high -- the lowest since late 2014. Many healthcare stocks are among those more than 20% from an annual high, including biotechs Mallinckrodt PLC (NYSE:MNK) and Perrigo Company plc Ordinary Shares (NYSE:PRGO), as well as healthcare technology concern Cerner Corporation (NASDAQ:CERN).  


SPX chart 2 Dec 13



Let us help you profit from market volatility. Target big gains in short order with a 30-day trial of Schaeffer's Weekly Volatility Trader!
 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Schaeffer's Daily Bulletin Offer
 


 


 
Special Offers from Schaeffer's Trading Partners